// company-profile
Kailera Therapeutics, Inc. Insider Trading
KLRAEvery SEC Form 4 insider trading filing for Kailera Therapeutics, Inc. (KLRA) — open-market buys and sells by directors and officers, option exercises, and cluster activity, updated as each filing is reported to the SEC.
ExchangeNasdaqSectorPharmaceutical PreparationsInc.DEFilings19Insiders27
// api This Kailera Therapeutics, Inc. insider-trading data is served live by the Form4API insider trading API. Get the same data via API.
curl "https://api.form4api.com/v1/transactions?ticker=KLRA" -H "X-Api-Key: YOUR_API_KEY"// activity-summary
No insider transactions in the last 30 days.
// 90-day insight
Over the last 90 days, Kailera Therapeutics, Inc. insiders bought $200K across 3 transactions with no open-market sales.
- Most active insider: Renaud Ronald C JR with 2 transactions totaling $200K.
- Largest single purchase: $200K by Renaud Ronald C JR on Jun 9, 2026.
Activity skews bullish — buys outpace sales.
Insider Transactions
Sourced from SEC EDGAR Form 4 filings. Updated hourly.
| Date | Insider | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jul 6, 2026 | Tregoning Kathleen | KLRA | Award | 175,000 | $0.00 | $0K |
| Jun 9, 2026 | Renaud Ronald C JR | KLRA | Option Exercise | 38,094 | $0.00 | $0K |
| Jun 9, 2026 | Renaud Ronald C JR | KLRA | Option Exercise | 38,094 | $5.25 | $200K |
| Apr 20, 2026 | Bain Capital Life Sciences Investors, LLC | KLRA | C | 16,875,000 | — | — |
| Apr 20, 2026 | Koppel Adam | KLRA | Purchase | 1,562,500 | $16.00 | $25.00M |
42 more transactions hidden
Free account · No credit card required
Building something? Get API access →